Article
Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases.
The pharmacogenomics journal - 22 May 2018
Wang Z-M, Luo J-Q, Xu L-Y, Zhou H-H, Zhang W
Abstract excerpt
Wnt signaling regulates a broad variety of processes in both embryonic development and various diseases. Recent studies indicated that some genetic variants in Wnt signaling pathway may serve as predictors of diseases. Low-density lipoprotein receptor protein 6 (LRP6) is a Wnt co-receptor with essential functions in the Wnt/β-catenin pathway, and mutations in LRP6 gene are linked to many complex human diseases,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
